DARE
DARE
NASDAQ · Pharmaceuticals

Dare Bioscience Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks
$1.36
+0.06 (+4.62%)
As of Mar 22, 10:54 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +202.9% upside
Low Target $2.96
Average Target $4.12
High Target $5.49
Current Price $1.36
Current
$1.36
Target
$4.12
$2.96 $4.12 avg $5.49
Scenario Analysis
Bear Case
$2.96
117.6%
Low target
Base Case
$4.12
+202.9%
Avg target
Bull Case
$5.49
+303.7%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$9.19
-85.2% from high
52-Week Low
$1.27
+7.1% from low
Target vs 52W High
$4.12
-55.2% vs high
Next Earnings Report
Mar 30, 2026 · After Market Close
3d
until earnings
EPS Est: $-0.44
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +809.8%